Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity
Open Access
- 1 August 2015
- journal article
- Published by Elsevier BV in Journal of Traditional Chinese Medicine
- Vol. 35 (4), 440-444
- https://doi.org/10.1016/s0254-6272(15)30122-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in ChinesePLOS ONE, 2013
- Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signalingInternational Journal of Oncology, 2011
- Colon cancerCritical Reviews in Oncology/Hematology, 2010
- Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κBEuropean Journal of Pharmacology, 2010
- Colorectal cancerThe Lancet, 2010
- NF-κB Signaling Pathway, Inflammation and Colorectal CancerCellular & Molecular Immunology, 2009
- Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cellsMelanoma Research, 2008
- Systemic Therapy for Colorectal CancerThe New England Journal of Medicine, 2005
- Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of ApoptosisOnline Journal of Public Health Informatics, 2004
- Disease‐free survival and recurrence after resection of colorectal carcinomaJournal of Surgical Oncology, 1981